Article
Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia.
Pharmacogenetics and genomics - 1 Nov 2007
Gätke Mona R, Bundgaard Jens R, Viby-Mogensen Jørgen
Abstract excerpt
BACKGROUND: Butyrylcholinesterase (BChE) hydrolyses the neuromuscular blocking agents, succinylcholine and mivacurium used during general anaesthesia. Hereditary low BChE activity may result in an extensively prolonged duration of action of these drugs, especially in patients who are homozygous for the atypical or silent variants. We present three novel mutations in the butyrylcholinesterase gene (BCHE)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
